MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
Ribon Therapeutics, Inc.
Finance & Acquisition: Ribon Therapeutics
Parents
Ribon Therapeutics, Inc.
Children
2024: PARP biotech backed by more than five pharmas closes after nine years_ endpts
20245: Ribon had raised about $200 million from at least half a dozen pharmaceutical companies or their corporate investment arms, including AbbVie, Pfizer, Bristol Myers Squibb, Johnson & Johnson, Novartis and Takeda. It also secured financial backing from a well-known roster of firms like Deerfield, GV and The Column Group.
Jumps
Key People: Ribon Therapeutic
Organization & Developments: Ribon Therapeutics